NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 23 04:00PM ET
29.02
Dollar change
-0.30
Percentage change
-1.02
%
Index- P/E25.57 EPS (ttm)1.13 Insider Own0.07% Shs Outstand586.83M Perf Week0.83%
Market Cap17.03B Forward P/E12.32 EPS next Y2.36 Insider Trans0.00% Shs Float586.39M Perf Month20.07%
Income665.99M PEG1.55 EPS next Q0.48 Inst Own5.99% Short Float0.12% Perf Quarter24.50%
Sales20.92B P/S0.81 EPS this Y27.42% Inst Trans1.18% Short Ratio1.56 Perf Half Y31.31%
Book/sh26.46 P/B1.10 EPS next Y13.27% ROA1.84% Short Interest0.70M Perf Year35.48%
Cash/sh1.97 P/C14.72 EPS next 5Y16.55% ROE4.36% 52W Range17.93 - 30.46 Perf YTD28.18%
Dividend Est.0.87 (3.01%) P/FCF9.24 EPS past 5Y-14.87% ROI2.58% 52W High-4.73% Beta0.87
Dividend TTM0.79 (2.71%) Quick Ratio1.08 Sales past 5Y1.38% Gross Margin24.46% 52W Low61.85% ATR (14)0.66
Dividend Ex-DateMay 23, 2025 Current Ratio1.46 EPS Y/Y TTM27.17% Oper. Margin8.02% RSI (14)66.18 Volatility1.76% 1.99%
Employees113840 Debt/Eq0.75 Sales Y/Y TTM-0.91% Profit Margin3.18% Recom2.68 Target Price28.24
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q106.71% Payout79.39% Rel Volume1.03 Prev Close29.32
Sales Surprise4.47% EPS Surprise11.88% Sales Q/Q0.19% EarningsMay 06 BMO Avg Volume446.93K Price29.02
SMA205.14% SMA5013.39% SMA20027.43% Trades Volume459,818 Change-1.02%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Upgrade BofA Securities Underperform → Neutral
Nov-06-24Initiated Berenberg Buy $25.60
Jan-08-24Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-24-23Upgrade HSBC Securities Reduce → Hold
Nov-17-23Upgrade Societe Generale Hold → Buy
Aug-14-23Downgrade UBS Buy → Neutral
Aug-01-23Resumed Citigroup Neutral
Jul-12-23Initiated Goldman Buy
Mar-07-23Initiated Bernstein Mkt Perform
Jan-03-23Downgrade Jefferies Buy → Underperform $14 → $11.70
May-22-25 11:45AM
09:40AM
May-15-25 12:00PM
09:50AM
08:06AM
07:08AM Loading…
May-09-25 07:08AM
05:44AM
04:36AM
May-08-25 03:08AM
03:08AM
May-07-25 08:09PM
12:30PM
May-06-25 10:25AM
09:40AM
07:00AM
11:09AM Loading…
May-05-25 11:09AM
May-02-25 11:05AM
08:30AM
May-01-25 11:46AM
11:34AM
11:32AM
10:40AM
09:13AM
Apr-30-25 11:25AM
Apr-29-25 01:10PM
Apr-28-25 01:18PM
11:24AM
Apr-27-25 05:08AM
Apr-25-25 12:50PM
12:48PM
01:02PM Loading…
Apr-24-25 01:02PM
11:36AM
Apr-23-25 12:39PM
09:40AM
Apr-21-25 09:57AM
Apr-17-25 09:40AM
08:50AM
Apr-16-25 09:07AM
06:30AM
Apr-15-25 09:45AM
Apr-14-25 09:40AM
Apr-11-25 09:50AM
Apr-10-25 01:19PM
09:03AM
Apr-09-25 08:57AM
Apr-07-25 09:40AM
Apr-04-25 12:37PM
11:02AM
09:40AM
08:27AM
Apr-03-25 11:30AM
Apr-02-25 03:34PM
08:35AM
Apr-01-25 10:41AM
10:02AM
09:42AM
09:40AM
Mar-31-25 08:47AM
Mar-28-25 11:30AM
10:25AM
Mar-27-25 05:00AM
05:00AM
Mar-26-25 11:59AM
11:44AM
07:47AM
Mar-25-25 10:39AM
Mar-24-25 11:50AM
10:15AM
10:15AM
07:41AM
Mar-20-25 09:40AM
09:38AM
05:00AM
Mar-19-25 10:15AM
Mar-13-25 08:00AM
Mar-04-25 02:50AM
Feb-25-25 10:15AM
07:00AM
Feb-24-25 08:00AM
Jan-07-25 07:57AM
Dec-23-24 09:00AM
Dec-20-24 11:23AM
Nov-19-24 09:00AM
Nov-06-24 06:33AM
Nov-05-24 10:19AM
07:00AM
02:05AM
Oct-21-24 11:04AM
Sep-10-24 07:51PM
Sep-04-24 08:00AM
Aug-07-24 08:57PM
Jul-30-24 02:43PM
07:00AM
Jul-08-24 07:59AM
Jun-19-24 09:40AM
Jun-12-24 08:00AM
Jun-11-24 02:23PM
Jun-07-24 11:02AM
May-30-24 07:07AM
May-23-24 12:33PM
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.